Improving the Therapeutic benefit of immunotherapy in Neuroblastoma by combining autophagy inhibitor and anti-PD-i

Project Details

AcronymCombiN
StatusActive
Effective start/end date1/01/23 → 31/12/26

Funding

  • Stiftelsen Cancera: €292,996.00